No Data
No Data
Express News | Rigel Appoints Mark W. Frohlich, M.d. to Board of Directors
Press Release: Rigel Appoints Mark W. Frohlich, M.D. to Board of Directors
Rigel Pharmaceuticals, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Rigel Pharmaceuticals Price Target Raised to $55.00/Share From $49.00 by Citigroup
Citi Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Raises Target Price to $55
Express News | Rigel Pharmaceuticals Inc : Citigroup Raises Target Price to $55 From $49